Home Yunshi Software Secures Tens of Millions in USD Series B Funding, Files for IPO to Lead Life Sciences Industry Digital Transformation

Yunshi Software Secures Tens of Millions in USD Series B Funding, Files for IPO to Lead Life Sciences Industry Digital Transformation

Dec 02, 2019 09:26 CST Updated 09:26
ForceClouds

SaaS Service Provider in the Pharmaceutical Industry

ForceClouds recently completed a tens-of-millions-of-US-dollars Series B financing round. The round was led by F-Prime Capital, with participation from Anshun Fuhai High-Tech Service Industry Venture Investment Fund and Lanhu Capital.

 

Zhang Yingnan, Founder and CEO of ForceClouds, stated: “With financial backing from both new and existing investors, ForceClouds is poised to become the absolute leader in the informatization of China’s life sciences industry.” Hu Junping, President of ForceClouds, added: “Moving forward, ForceClouds will continue to increase its investment in product R&D, thereby delivering higher-quality products and services to ensure customer success!”

 

Cai Yuanxun, Partner at Fidelity International Capital (FIC), the lead investor in this round, stated: “As a global proprietary investment institution backed by Fidelity Investments, our use of proprietary capital enables us to fulfill our commitment to long-term partnership with companies as they grow, particularly in the healthcare sector, which is characterized by extended development cycles. We firmly believe that information technology is one of the key drivers of the long-term, healthy development of China’s healthcare industry. ForceClouds has been deeply engaged in China’s healthcare informatization field for many years and has already gained the recognition and trust of dozens of large multinational enterprise clients, effectively helping them enhance their digital operational capabilities. We are confident that ForceClouds will replicate its experience serving multinational corporate clients to benefit a broader range of customers in China’s healthcare sector, helping them achieve success.”

 

Chen Liwei, Partner at the Anshun Fuhai High-Tech Service Industry Venture Capital Fund, a co-investor in this round, stated: “Leveraging the resource advantages of Guizhou’s National Big Data Center, Anshun Fuhai is committed to investing in outstanding industrial internet enterprises that align with national strategic directions. There is currently a significant gap between China and the United States in the medical informatics sector, where ForceClouds operates. In recent years, ForceClouds has made substantial progress, with its products becoming increasingly mature and its service system continuously improving. Our decision to invest in ForceClouds was primarily driven by the observation that it has already gained competitive advantages in certain product areas while competing against foreign giants. We believe that, given time, ForceClouds has the capability to secure a place in the international market.”

 

Yin Ming, Founding Partner of Lanhu Capital, a co-investor in this round, stated: “Lanhu Capital firmly believes that the next decade will be defined by investments in enhancing efficiency in China, with software and informatization playing a pivotal role. ForceClouds is dedicated to empowering the traditional healthcare industry through enterprise software services, a sector characterized by substantial market potential and high competitive barriers. We are confident that under the leadership of Ying Nan and Jun Ping, ForceClouds will continue to solidify its first-mover advantage and attract more leading industry clients in its future development.”

 

ForceClouds leverages advanced cloud platforms, big data analytics, and artificial intelligence technologies to provide simple, secure, efficient, and compliant cloud-based solutions for automated information management. These solutions serve companies in the pharmaceutical, medical device, animal health, crop science, and nutrition and healthcare industries, as well as clinical-related institutions such as CROs and hospitals. Currently, over 50,000 enterprise users—including multinational pharmaceutical and medical device giants such as AstraZeneca, Bayer, Merck & Co., Thermo Fisher Scientific, B. Braun, and bioMérieux, as well as leading domestic enterprises like Hengrui Medicine, Hansoh Pharmaceutical, Kanion Pharmaceutical, and Tasly Group—are utilizing ForceClouds’ high-quality products and services.